BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7522963)

  • 21. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
    Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
    Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
    Morony S; Capparelli C; Lee R; Shimamoto G; Boone T; Lacey DL; Dunstan CR
    J Bone Miner Res; 1999 Sep; 14(9):1478-85. PubMed ID: 10469275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of hypercalcemia with tumors producing colony-stimulating factor(s).
    Kondo Y; Sato K; Ohkawa H; Ueyama Y; Okabe T; Sato N; Asano S; Mori M; Ohsawa N; Kosaka K
    Cancer Res; 1983 May; 43(5):2368-74. PubMed ID: 6600966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
    Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
    J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA; Yoneda T; Yates AJ; Mundy GR
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.
    Yoneda T; Nakai M; Moriyama K; Scott L; Ida N; Kunitomo T; Mundy GR
    Cancer Res; 1993 Feb; 53(4):737-40. PubMed ID: 8428354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1.
    Guise TA; Garrett IR; Bonewald LF; Mundy GR
    J Bone Miner Res; 1993 May; 8(5):583-7. PubMed ID: 8511985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo.
    Endo Y; Nakamura M; Kikuchi T; Shinoda H; Takeda Y; Nitta Y; Kumagai K
    Calcif Tissue Int; 1993 Mar; 52(3):248-54. PubMed ID: 8481841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
    Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of esophageal carcinoma with hypercalcemia caused by PTH-rP--the effect of therapy on the bone and calcium metabolism].
    Nakayama Y; Okuno S; Miki T; Nishizawa Y; Morii H
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1294-9. PubMed ID: 1291340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Kozak S; Rizzoli R; Trechsel U; Fleisch H
    Cancer Res; 1987 Dec; 47(23):6193-7. PubMed ID: 3677071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.
    Xu Z; Hurchla MA; Deng H; Uluçkan O; Bu F; Berdy A; Eagleton MC; Heller EA; Floyd DH; Dirksen WP; Shu S; Tanaka Y; Fernandez SA; Rosol TJ; Weilbaecher KN
    J Biol Chem; 2009 Feb; 284(7):4658-66. PubMed ID: 19059914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged and ubiquitous inhibition by interferon gamma of bone resorption induced by parathyroid hormone-related protein, 1,25-dihydroxyvitamin D3, and interleukin 1 in fetal mouse forearm bones.
    Fujii Y; Sato K; Kasono K; Satoh T; Fujii T; Shizume K
    Calcif Tissue Int; 1990 Sep; 47(3):178-82. PubMed ID: 2121324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of antigen-presenting cell function by alendronate in vitro.
    Sansoni P; Passeri G; Fagnoni F; Mohagheghpour N; Snelli G; Brianti V; Engleman EG
    J Bone Miner Res; 1995 Nov; 10(11):1719-25. PubMed ID: 8592949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats.
    Takahashi K; Shirahata A; Fukushima S; Kokubo S; Teramura K; Usuda S
    Jpn J Pharmacol; 1998 Feb; 76(2):155-63. PubMed ID: 9541278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypocalcemic effect of elcatonin in mouse models for humoral hypercalcemia of malignancy].
    Isogai Y; Hori M
    Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):199-208. PubMed ID: 7774857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.